Overview

While the basic principles of personalized medicine and pharmacogenomics has been covered by numerous texts, there are none to date that focuses on the specific tests themselves that are in current clinical practice and those that are being proposed for implementation in the near future. Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory focuses almost entirely on the specifics of each test that is needed to implement these tests into a clinical laboratory. This volume presents the first compilation of the tests currently in routine clinical use. The chapter authors of this unique and invaluable title comprise a range of renowned authorities and investigators who have conducted the essential clinical trials necessary to justify pharmacogenomic testing today. The book is divided into four parts: Basic Concepts, Specific Pharmacogenomic Targets, Drugs that Cause Delayed Hypersensitivity, and Miscellaneous Drugs. Each author provides a pharmacologic background on the target drug, the need for pharmacogenomic testing, and how results can be translated into clinical decisions. Where appropriate, case studies are given to illustrate typical clinical scenarios. An extensive bibliography is provided so that the reader can refer to the original studies. This well-designed resource will appeal to clinical laboratory directors who are contemplating or assigned the task of establishing a pharmacogenomics laboratory and a wide range of clinicians who must interpret results of testing. Focused and immensely useful, Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory is a timely and outstanding contribution to the literature and will be instrumental in defining this rapidly growing field.

Full Product Details

Author:   Alan H. B. Wu ,  Kiang-Teck J. Yeo
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Dimensions:   Width: 15.50cm , Height: 2.00cm , Length: 23.50cm
Weight:   0.600kg
ISBN:  

9781607612827

ISBN 10:   1607612828
Pages:   272
Publication Date:   17 February 2011
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Awaiting stock  
The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you.

Table of Contents

Part 1.        Basic concepts       Chapter 1.      Issues in Translation of Pharmacogenomics into Clinical Practice.                         Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu Chapter 2.      Molecular Diagnostic Methods in Pharmacogenomics                        Nikolina Babic*, Loren J. Joseph, Kiang-Teck J. Yeo Chapter 3.      Economics of pharmacogenomic testing in clinical practice                         Alan H.B. Wu Chapter 4.      From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.   Part 2.        Specific pharmacogenomic targets: Chemotherapeutics Chapter 5.      Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6.      Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7.      Thiopurines Terreia S. Jones, Mary V. Relling   Part 3.       Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9.      Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10.    DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11.    The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.   Part 4.        Drugs that cause delayed hypersensitivity Chapter 12.    Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13.    Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.   Part 2.        Specific pharmacogenomic targets: Chemotherapeutics Chapter 5.      Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6.      Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7.      Thiopurines Terreia S. Jones, Mary V. Relling   Part 3.        Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9.      Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10.    DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11.    The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.   Part 4.        Drugs that cause delayed hypersensitivity Chapter12.    Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13.    Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang

Reviews

From the reviews: The book is written for clinical laboratory directors 'contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ! allied health practitioners, regulators, reimbursers, and test device manufacturers. ! The writing is concise, clear, and accessible for what might be considered a complex topic. ! Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011)

From the reviews: The book is written for clinical laboratory directors `contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011)

From the reviews: The book is written for clinical laboratory directors 'contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011)

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions